Chew, D. S., Cowper, P. A., Bigelow, R., Li, Y., Anstrom, K., Davidson-Ray, L. D., … Mark, D. B. (2021). Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial. In CIRCULATION (Vol. 144, pp. E586–E586).

Chew, Derek S., Patricia A. Cowper, Robert Bigelow, Yanhong Li, Kevin Anstrom, Linda D. Davidson-Ray, Adrian F. Hernandez, Christopher M. O’Connor, Paul Armstrong, and Daniel B. Mark. “Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial.” In CIRCULATION, 144:E586–E586, 2021.

Chew DS, Cowper PA, Bigelow R, Li Y, Anstrom K, Davidson-Ray LD, et al. Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial. In: CIRCULATION. 2021. p. E586–E586.

Chew, Derek S., et al. “Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial.” CIRCULATION, vol. 144, no. 25, 2021, pp. E586–E586.

Chew DS, Cowper PA, Bigelow R, Li Y, Anstrom K, Davidson-Ray LD, Hernandez AF, O’Connor CM, Armstrong P, Mark DB. Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial. CIRCULATION. 2021. p. E586–E586.